Home › Dermatitis › Illinois
Dermatitis clinical trials in Illinois
3 studies for Dermatitis are looking for participants at sites in Illinois.
Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis
- Arcutis Site 320, Chicago
RecruitingPhase 3
Ages 6 and older · All sexes · Updated Nov 6, 2026 · NCT07916480A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Endeavor Health, Skokie
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 28, 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 2, Rolling Meadows
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Aug 12, 2026 · NCT07037901From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.